NCT06797518View on ClinicalTrials.gov

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 21, 2025

Primary Completion Date

November 27, 2027

Study Completion Date

November 27, 2027

Conditions
Glomerulonephritis, IGAImmunoglobulin A Nephropathy
Interventions
DRUG

Iptacopan

LNP023 oral capsule 200 mg b.i.d

Trial Locations (4)

30518

RECRUITING

Nephronet Clinical, Buford

43000

RECRUITING

Novartis Investigative Site, Kuala Lumpur

77054

RECRUITING

Prolato Clinical Research Center, Houston

83202

RECRUITING

CaRe Research, Chubbuck

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY